Digital Frontiers Health 2022 - day 2 And the LIVE coverage continues as we head into Day Two... This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that wo
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.